86 related articles for article (PubMed ID: 15896791)
21. Role of Stat3 in regulating p53 expression and function.
Niu G; Wright KL; Ma Y; Wright GM; Huang M; Irby R; Briggs J; Karras J; Cress WD; Pardoll D; Jove R; Chen J; Yu H
Mol Cell Biol; 2005 Sep; 25(17):7432-40. PubMed ID: 16107692
[TBL] [Abstract][Full Text] [Related]
22. Regulation of protein Citrullination through p53/PADI4 network in DNA damage response.
Tanikawa C; Ueda K; Nakagawa H; Yoshida N; Nakamura Y; Matsuda K
Cancer Res; 2009 Nov; 69(22):8761-9. PubMed ID: 19843866
[TBL] [Abstract][Full Text] [Related]
23. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
Johnson TM; Attardi LD
Cell Death Differ; 2006 Jun; 13(6):902-8. PubMed ID: 16557272
[No Abstract] [Full Text] [Related]
24. Hzf and hCAS/CSE1L: making the right choice in p53-mediated tumour suppression.
Ewings KE; Ryan KM
Cell Res; 2007 Oct; 17(10):829-31. PubMed ID: 17934491
[No Abstract] [Full Text] [Related]
25. Determination of critical network interactions: an augmented Boolean pseudo-dynamics approach.
Soni AS; Jenkins JW; Sundaram SS
IET Syst Biol; 2008 Mar; 2(2):55-63. PubMed ID: 18397116
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic viruses.
Pfister H
Cancer Treat Res; 2009; 146():133-42. PubMed ID: 19415199
[No Abstract] [Full Text] [Related]
27. Development of physiological models to study stress protein responses.
Hupp TR
Methods Mol Biol; 2000; 99():465-83. PubMed ID: 10909099
[No Abstract] [Full Text] [Related]
28. Multi-scale modeling of cell survival and death mediated by the p53 network: a systems pharmacology framework.
Wang Y; Guo Z; Chen X; Zhang W; Lu A; Wang Y
Mol Biosyst; 2015 Nov; 11(11):3011-21. PubMed ID: 26299837
[TBL] [Abstract][Full Text] [Related]
29. Possibility that transmissible viruses might be involved in the etiology of human cancer.
Lusso P
Rev Clin Exp Hematol; 2003 Dec; 7(4):327-8. PubMed ID: 15129645
[No Abstract] [Full Text] [Related]
30. Enhancing community integrity of networks against multilevel targeted attacks.
Ma L; Gong M; Cai Q; Jiao L
Phys Rev E Stat Nonlin Soft Matter Phys; 2013 Aug; 88(2):022810. PubMed ID: 24032886
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic viruses and cancer.
Luo GG; Ou JH
Virol Sin; 2015 Apr; 30(2):83-4. PubMed ID: 25924992
[No Abstract] [Full Text] [Related]
32. Sequential defense against random and intentional attacks in complex networks.
Chen PY; Cheng SM
Phys Rev E Stat Nonlin Soft Matter Phys; 2015 Feb; 91(2):022805. PubMed ID: 25768550
[TBL] [Abstract][Full Text] [Related]
33. p53: death star.
Vousden KH
Cell; 2000 Nov; 103(5):691-4. PubMed ID: 11114324
[No Abstract] [Full Text] [Related]
34. Formal verification confirms the role of p53 protein in cell fate decision mechanism.
Mahmoud EA; Herajy M; Ziedan IE; Shehata HI
Theory Biosci; 2023 Feb; 142(1):29-45. PubMed ID: 36510032
[TBL] [Abstract][Full Text] [Related]
35. Obituary for guy de thé.
de Thé H; Gessain A
Retrovirology; 2015 Jan; 12():7. PubMed ID: 25636333
[No Abstract] [Full Text] [Related]
36. Robustness of integrin signaling network.
Kness M; Wang G; Zaman MH
J Chem Phys; 2009 Jun; 130(23):235103. PubMed ID: 19548764
[TBL] [Abstract][Full Text] [Related]
37. The diversity of human cancer viruses.
Butel JS; Fan H
Curr Opin Virol; 2012 Aug; 2(4):449-52. PubMed ID: 22819022
[No Abstract] [Full Text] [Related]
38. A Virological Perspective on Cancer.
Damania B
PLoS Pathog; 2016 Feb; 12(2):e1005326. PubMed ID: 26866686
[No Abstract] [Full Text] [Related]
39. Optimization of network robustness to waves of targeted and random attacks.
Tanizawa T; Paul G; Cohen R; Havlin S; Stanley HE
Phys Rev E Stat Nonlin Soft Matter Phys; 2005 Apr; 71(4 Pt 2):047101. PubMed ID: 15903820
[TBL] [Abstract][Full Text] [Related]
40. Human tumors and human specific viruses.
Mathé G
Biomed Pharmacother; 1997; 51(6-7):241-2. PubMed ID: 9309243
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
